Annual Report 2026
Source: Nse
Industrials stocks · SME cap · NSE
Saakshi Medtech and Panels Ltd. manufactures integrated control systems, EV solutions, precision medtech products (X-ray machines), engineered metal assemblies for locomotives and aerospace, and wire harnesses. It serves industrial automation, medical devices, and defense/aerospace sectors.
full bull SMA stack · SMA20 +16.2% / mo · MACD − · near 52W high
Latest mapped FPI equity flow was not positive. View sector evidence
Adjusted completed-session prices, rebased to 100
Weak fundamentals, while price trend supports entry. This looks more like momentum/speculation than a clean fundamental investment setup.
Weak U-Score but strong trend: momentum may be ahead of fundamentals.
Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.
Revenue -6.6% · PAT +0.0% YoY
Price trend and sector-relative-strength timing.
Legacy margin-of-safety estimate; the revised evidence label remains in shadow validation.
Financial-only signal; management claim evidence is not sufficient yet.
Fundamentals, quarterly history, margins, returns and balance-sheet evidence
Rev -7% YoY · PAT 0% YoY · margin expansion · operating leverage
| Metric | This quarter | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹57 Cr | -6.6% | -1.7% |
| EBITDA | ₹12 Cr | NDF | +9.1% |
| Operating margin | 20.0% | NDF | +200 bps |
| PAT | ₹6 Cr | +0.0% | -14.3% |
| PAT margin | 10.5% | NDF | -154 bps |
NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.
Updated 20/10/2026
Trend interpretation, Stage 2, relative strength, volume and indicator evidence
Trend is constructive — long-term uptrend intact. RSI 65.
Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.
U-Score 36 · legacy U-Score band WATCHLIST · valuation evidence and comparable companies
Top U-Score contributors and drags from the latest stored fundamentals.
For this sector, IndiaPulse uses a blended lens rather than relying on a single valuation ratio.
This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.
12 stored score snapshots. Latest stored move: +0 points.
Business-comparable peers in Industrials — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.
Growth engines, risks, management commitments and evidence-backed delivery
H1 FY25-26 revenue grew 30.36% YoY to Rs. 58.31 Cr, with PAT up 33.26% YoY to Rs. 6.01 Cr, driven by new customer orders and heat exchanger business, despite temporary wind business order deferrals.
The company demonstrated strong H1 FY25-26 financial performance with robust revenue and profit growth. Strategic certifications (AS9100D, ISO 13485) and new business initiatives are positive. However, the temporary easing of wind business order inflows due to strategic realignment warrants close monitoring.
Latest issuer-disclosed distribution across 4 reported categories.
AS9100D certification validates precision for flight-critical components, unlocking high-value contracts in defense and aerospace.
ISO 13485:2016 certification for X-ray equipment manufacturing is critical for accessing the booming domestic medical device market.
Company achieved "new customer std line orders" in H1 FY25-26.
"Heat exchanger business" was an achievement in H1 FY25-26 and is part of future outlook.
A new facility was added in 2024 for expansion purposes.
Addition of radiator business in 2025.
A new, dedicated wind manufacturing facility is under development, scheduled to commence operations in the next fiscal year.
AS9100D certification positions Saakshi for high-value, long-lifecycle contracts in the defense and aerospace supply chain.
ISO 13485:2016 certification is critical for accessing the booming domestic medical device market.
"New customer std line orders" and "Heat exchanger business" were cited as achievements.
Strategic realignment of the wind business resulted in a temporary easing of order inflows.
During the wind business transition, a number of orders were deferred, impacting short-term overall order flow.
Strategic realignment in the wind business led to temporary easing of order inflows and deferrals, posing a risk until the new facility is operational.
Integrated control systems & EV Solutions constitute 58.99% of H1 FY25-26 revenue, indicating concentration risk.
Issuer guidance and extracted claims are tracked against later reported outcomes. Treat these as management statements, not IndiaPulse forecasts.
The presentation provides half-yearly data, allowing for both year-on-year comparison to assess annual growth trends and sequential comparison to evaluate recent momentum and execution.
H1 FY25-26 revenue increased to Rs. 58.31 Cr from Rs. 44.73 Cr in H1 FY24-25, a 30.36% growth.
H1 FY25-26 revenue increased to Rs. 58.31 Cr from Rs. 48.27 Cr in H2 FY24-25, a 20.79% growth.
EBITDA margin improved slightly to 17.17% in H1 FY25-26 from 17.01% in H1 FY24-25.
PAT margin improved to 10.31% in H1 FY25-26 from 10.08% in H1 FY24-25.
Management plans to enter new business in Power Devices and semiconductors.
Management highlighted "New Heat exchangers Business" as part of future outlook.
Future outlook includes new Japanese customers in Compressor and new customers in Aerospace.
Management plans to enter "New Machine tool fabrication Business".
| Checkpoint | Current evidence | What to verify next |
|---|---|---|
| Wind Business Order Inflows | Temporary easing and order deferrals due to strategic realignment. | Resumption of order inflows and commissioning of the new dedicated wind manufacturing facility. |
| New Business Ramp-up | Heat exchanger business initiated, plans for power devices, aerospace, textile control panels. | Revenue contribution and margin profile from new businesses and customer wins. |
| Integrated Control Systems Growth | 58.99% of H1 FY25-26 revenue. | Sustained growth and market share in this dominant segment. |
Verification checkpoints are IndiaPulse research interpretation, not investment advice.
Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.
Limited evidence: Claim history is still being built. It ranks around the 59th percentile of the scored universe and 56th percentile within Industrials. Main check: results consistency is weak at 48/100.
This is a financial-behaviour screen, not a claim-tested management reliability verdict.
Financial behaviour is scored, but management claims do not yet have enough outcome checks.
overall median 67 · Industrials: 56th pctile, median 68 · SME: 77th pctile, median 64
8 documents have extracted text, but claim history is not strong enough yet.
0 claims extracted · No contradicted claim yet
Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.
Read low sub-scores as due-diligence warnings, not automatic sell signals.
Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.
Latest exchange and company disclosures found within the past two years.
Source: Nse
Source: Nse
Source: Nse
Source: Nse
Source: Nse
Source: Nse
Source: Nse